Compare PLSE & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLSE | PRA |
|---|---|---|
| Founded | 2014 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2016 | N/A |
| Metric | PLSE | PRA |
|---|---|---|
| Price | $14.39 | $24.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $22.00 | ★ $22.50 |
| AVG Volume (30 Days) | 167.2K | ★ 405.5K |
| Earning Date | 11-05-2025 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | $86,000.00 | ★ $1,120,385,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,002.94 | $1.24 |
| P/E Ratio | ★ N/A | $36.69 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.56 | $13.90 |
| 52 Week High | $25.00 | $24.41 |
| Indicator | PLSE | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 52.70 |
| Support Level | $13.82 | $24.09 |
| Resistance Level | $15.34 | $24.21 |
| Average True Range (ATR) | 0.78 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 28.88 | 56.82 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.